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Adipocyte lipid-binding protein (ALBP or aP2) is an
intracellular fatty acid-binding protein that is found in
adipocytes and macrophages and binds a large variety
of intracellular lipids with high affinity. Although intracellular lipids are frequently charged, biochemical studies of lipid-binding proteins and their interactions often
focus most heavily on the hydrophobic aspects of these
proteins and their interactions. In this study, we have
characterized the effects of KCl on the stability and lipid
binding properties of ALBP. We find that added salt
dramatically stabilizes ALBP, increasing its ⌬G of unfolding by 3–5 kcal/mol. At 37 °C salt can more than
double the stability of the protein. At the same time, salt
inhibits the binding of the fluorescent lipid 1-anilinonaphthalene-8-sulfonate (ANS) to the protein and induces direct displacement of the lipid from the protein.
Thermodynamic linkage analysis of the salt inhibition
of ANS binding shows a nearly 1:1 reciprocal linkage: i.e.
one ion is released from ALBP when ANS binds, and vice
versa. Kinetic experiments show that salt reduces the
rate of association between ANS and ALBP while simultaneously increasing the dissociation rate of ANS from
the protein. We depict and discuss the thermodynamic
linkages among stability, lipid binding, and salt effects
for ALBP, including the use of these linkages to calculate the affinity of ANS for the denatured state of ALBP
and its dependence on salt concentration. We also discuss the potential molecular origins and potential intracellular consequences of the demonstrated salt linkages
to stability and lipid binding in ALBP.

Adipocyte lipid-binding protein (ALBP or aP2)1 is a member
of the intracellular lipid-binding protein (iLBP) family, also
known collectively as the intracellular fatty acid-binding proteins. Members of the iLBP family are found in a number of
mammalian tissues, including liver, adipose, heart, brain, intestinal, and epithelial tissues (for reviews, see e.g. Refs. 1–3).
As its name suggests, ALBP is found predominantly in adipocytes, where it constitutes 1–5% of the total soluble protein. In
addition, ALBP is found in macrophages, where it has been
linked to the development of atherosclerosis (4, 5). ALBP has
also been implicated in the development of type II diabetes (6).
Like most iLBPs, ALBP can bind a number of fatty acids of at
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least 14 carbons as well as other hydrophobic ligands with
carboxylate or sulfonate moieties in its large, water-filled cavity (reviewed in Ref. 4). ALBP also tightly binds the fluorescent
probe 1-anilinonaphthalene-8-sulfonate (ANS) (7, 8). ANS
binds specifically in the ALBP lipid binding cavity (see Fig. 1),
is a competitive inhibitor of fatty acid binding, and produces a
large increase in fluorescence upon binding (7, 8).
Members of the iLBP family share remarkably similar tertiary structures. The iLBP fold consists of a 10-strand antiparallel ␤-barrel and a helix-turn-helix cap (see Fig. 1). They all
possess a ligand binding cavity of ⬃1000 Å3 located in the top
half of the ␤-barrel (4). In contrast, the amino acid sequence
homology between family members ranges from 23 to 69%,
with 39 highly conserved residues (4). In addition, iLBPs each
have distinct surface charge potentials (10). ALBP has a nearly
hemispherically distributed surface charge potential: mostly
positively charged on the top and mostly negatively charged on
the bottom (10). The varied charge topologies of the different
iLBPs suggest that surface charge may play an important role
in differentiating them in vivo.
The role that surface charge plays in iLBP function has to
date been predominantly characterized in a series of studies by
Storch and associates (11–13), which examine the interactions
of iLBPs with lipid vesicles. These studies have demonstrated
that ALBP transfers a fluorescent fatty acid to negatively
charged lipid membranes more rapidly than to neutral or positively charged membranes (12), that the transfer involves
direct collision/interaction of ALBP and the vesicle (11, 12), and
that salt attenuates the transfer reaction (12). Neutralizing the
surface lysines of ALBP by acetylation also inhibits the ability
of ALBP to form complexes with anionic vesicles (13). These
studies demonstrate that electrostatic attraction is directly
involved in the mediation of ALBP-membrane interactions.
In addition to the surface electrostatic topologies and the
ALBP-membrane interaction studies mentioned above, a variety of other recent studies support the significance of electrostatic effects in iLBP-lipid and ANS-protein interactions. 1)
Mutation of charged residues in the binding cavity of intestinal
fatty acid-binding protein can change the lipid binding specificity of the protein (14). 2) The binding of ANS to intestinal
fatty acid-binding protein has been observed to be dependent
on ionic strength (I) at low NaCl concentrations, and this observation was attributed to an electrostatic screening effect
(15). 3) Recent studies of “nonspecific” ANS surface binding to
a series of different proteins using titration calorimetry concluded that most ANS molecules bind predominantly via electrostatic association and to a lesser extent via hydrophobic
interactions (16). 4) In ANS displacement assays, ALBP has
been shown to bind retinoic acid, which has a carboxylate
group, with moderate affinity, whereas the protein exhibits
negligible affinity for retinol (7). Thus, whereas in one sense it
might seem unusual to characterize electrostatic effects on
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ANS Binding—The binding of ANS to ALBP was monitored using a
FluoroMax-2 fluorometer. ANS concentrations in ethanol were determined using the extinction coefficient 7800 M⫺1 cm⫺1 (Molecular
Probes, Inc., Eugene, OR). ANS in buffer plus 1% ethanol was titrated
into protein (in 10 mM potassium phosphate, pH 7.5, containing concentrations of KCl as noted) and using protein concentrations near 0.05
M. Samples were incubated for 2 min with stirring, and then fluorescence was monitored with 5-nm slits and excitation and emission wavelengths of 369 and 470 nm. Fluorescence was corrected for volume
increase during the titration. A corresponding titration of the background fluorescence of ANS titrated into buffer was collected and subtracted from each individual binding titration. The resulting fluorescence titrations were analyzed using a single-site binding isotherm,
F ⫽ 共Fmax*[ANS]/Kd)/(1 ⫹ [ANS]/Kd兲
FIG. 1. Structure and electrostatic surface topology of ALBP.
The panel on the right shows a ribbon diagram of the tertiary structure
of ALBP with ANS bound in the lipid binding cavity (Protein Data Bank
code 2ANS (8)). The panel on the left shows the electrostatic surface
potential topology of ALBP calculated using the program GRASP (9), as
described previously (10). Both depictions of the protein are in the same
orientation. In the electrostatic potential depiction, blue represents
positive potential, red is negative potential, and white is neutral.

interactions that are frequently considered to be predominantly hydrophobic, it is becoming increasingly clear that electrostatic effects are a major regulator of lipid-protein interactions. This has led us to investigate the effects of salt on ALBP.
The results demonstrate and quantitate the regulatory effects
of salt on the function and stability of ALBP.
EXPERIMENTAL PROCEDURES

Purification of ALBP—ALBP was purified as described previously
(17, 18). The pRSET plasmid for overexpression of murine ALBP was a
gift from Dave Bernlohr at the University of Minnesota. An extinction
coefficient of 15,500 M⫺1 cm⫺1 was used to determine protein concentrations (19). Protein was stored at ⫺70 °C until use.
Chemical Denaturations—For chemical denaturation studies, ALBP
was first dialyzed extensively against appropriate buffers (10 mM potassium phosphate at pH 7.5, with varying KCl concentrations from 0 to
2 M). Urea stocks were deionized by stirring with AG 501-X8 deionizing
resin (5 g/100 ml of solution, obtained from Bio-Rad) for 1 h in water.
Urea concentrations were then determined by refractive index as described by Pace (20), and the stocks were incorporated into the appropriate buffers. Stepwise chemical denaturations were performed by
incubating individual aliquots of protein at 0.1– 0.2 mg/ml with buffered
urea for 1 h, well past the time required to reach equilibrium (data not
shown). For denaturations of ALBP with ANS bound, 100 M ANS was
included in all experimental buffers. This concentration of ANS is
saturating at all salt concentrations examined. Denaturation was monitored by scanning each sample in an Aviv model 202 circular dichroism
spectrophotometer from 225 to 213 nm in a quartz cuvette with a 0.2-cm
path length.
Reversibility of ALBP unfolding was determined at high (1 M) and
low (50 mM) salt concentrations by incubating ALBP in denaturing
levels of urea plus salt for 1 h, followed by dialysis to remove the urea.
Redenaturation was then performed, and full reversibility (recovery of
the same ⌬Gunfolding) was obtained.
Data Analysis of Denaturation Curves—The raw CD signal (in millidegrees) of each sample at 216, 217, and 218 nm was transformed into
molar ellipticity (⌬⑀) (21), and denaturation curves at each wavelength
were analyzed using the nonlinear form of the linear extrapolation
method (22).
(⌬N ⫹ mN[D]) ⫹ (⌬U ⫹ mU[D]) e⫺共⌬G N3 U/RT⫹mG[D]/RT兲
0

⌬ ⫽

⫺共⌬G0N3 U/RT⫹mG[D]/RT兲

1⫹e

(Eq. 1)

Here ⌬⑀ represents the molar ellipticity at a given wavelength (the
dependent variable), [D] is the molar denaturant concentration (the
independent variable), ⌬⑀N is the y intercept of the native state base
line, mN is the slope of the native state base line, ⌬⑀U is the y intercept
of the unfolded state baseline, mU is the slope of the unfolded state base
line, ⌬G0N3 U is the extrapolated free energy of unfolding in the absence
of denaturant, R is the gas constant, T is the temperature in Kelvin, and
mG (the “m value”) is the slope of the calculated dependence of ⌬G on
[D]. Data were fit using the program KaleidaGraph (Synergy Software,
Inc.).

(Eq. 2)

where Fmax is the maximum fluorescence obtained upon binding, [ANS]
is the concentration of ANS, and Kd is the dissociation constant of ANS
from ALBP. This equation assumes that the total concentration of ANS
is negligibly different from the free ANS concentration, which is true
when Kd ⬎⬎ [ALBP]. Fits of the isotherms with the lowest (tightest) Kd
values using a quadratic solution of the binding polynomial, which does
not make this assumption (23–25), yield the same Kd values within
error and verify the applicability of Equation 2 to these data. The lowest
(tightest) Kd values in this study, at the lowest salt concentrations,
are ⬃10 times higher than the [ALBP]. Data were fit using the program
KaleidaGraph.
It should be noted that the ANS binding activity of ALBP is extremely sensitive to storage and preparation conditions, particularly to
being stored in dilute form. In all of our experiments, protein was stored
at ⫺70 °C at a concentration greater than 3 mg/ml and thawed and
diluted immediately before use. Even short periods (e.g. 16 h) of incubation in dilute (⬍10 M) solution at 4 °C result in a significant loss of
binding affinity. In addition, the use of nitrocellulose filters for buffer
preparation results in interference in the fluorescence assay. Neither of
these problems affects the stability of ALBP.
Salt Linkage Analysis—Linked ion release upon binding of ANS to
ALBP was calculated using a basic linkage relationship (26, 27); e.g. for
KCl, the relationship is as follows.
{⭸ln1/Kd}/兵⭸ln[KCl]} ⫽ ⌬nions ⫽ ⌬nK⫹ ⫹ ⌬nCl⫺

(Eq. 3)

ANS

Thus, a plot of ln(1/Kd
) versus ln [KCl] will have a slope equivalent to the net number of ions that are bound or released when ANS
binds.
Direct Ligand Displacement—To examine the direct displacement of
ANS by salt, KCl was titrated into ANS-bound ALBP, and the decrease
in fluorescence as ANS was released was recorded. A background titration of buffer added to ANS-bound ALBP was subtracted from the salt
displacement data. The data were fit with a simple inverse isotherm,
YI ⫽ {[KCl]/IC50}/{1 ⫹ [KCl]/IC50}

(Eq. 4)

where YI is the normalized fluorescence, and IC50 is the concentration
of salt at 50% inhibition.
Stopped Flow Kinetic Analysis of ANS Binding to ALBP—Kinetics
experiments were performed using a Biologic SF3 stopped flow interfaced with an ISS fluorometer. ALBP and ANS were rapidly mixed, and
ANS fluorescence was monitored with excitation at 369 nm and emission at 470 nm. The assay buffer was 10 mM potassium phosphate, pH
7.5, 1% ethanol, and either 50 mM KCl or 1 M KCl. The resulting kinetic
association curves were fit to the single exponential equation,
F ⫽ 共Fmax ⫺ F0)䡠(1 ⫺ e⫺kobs(t ⫺ toffset)) ⫹ F0

(Eq. 5)

where F is the fluorescence (dependent variable), (Fmax ⫺ F0) is the
amplitude of the transition, kobs is the time constant of association, t is
the time after the completion of injection (independent variable), toffset
is the x axis offset, which accounts for mixing time and the dead time of
the instrument, F0 is the initial fluorescence before binding, and Fmax is
the maximum fluorescence upon completion of binding. All parameters
were allowed to float except F0, which was determined by observing the
fluorescence of ANS in buffer and was then fixed during fitting. The
association of ANS with ALBP is very fast, so experiments were conducted at 6 °C to minimize loss of data during the dead time (⬃3 ms).
For each concentration of ANS ⫹ ALBP, 5–12 shots over two different
time scales (100 ms and 1 s) were averaged and collated. Using this
technique, ⬃50% of the full extent of reaction can be captured (less for
faster processes, more for slower processes), which affords excellent
precision in the determination of kobs. Determined rates are not affected
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by the collection time scale, but averaging and obtaining high density
overlapping data throughout the complete course of the reaction significantly improves the precision of the fits. Kinetic curves were fit to both
single and double exponential functions with the result that all kinetic
curves were judged to be single exponential curves. It should be noted
that the sensitivity of ALBP to storage conditions, described under
“ANS Binding,” also appears to pertain to the kinetic behavior of the
protein. Carefully handled and stored protein consistently produced
well behaved single exponential kinetic curves.
For determination of the association (kon) and dissociation (koff) rate
constants, the relaxation time constants were plotted as a function of
the sum of the equilibrium concentrations of ANS plus ALBP (28).
Equilibrium concentrations of ANS and ALBP were determined by an
iterative fitting process (28). Briefly, 1/ (1/ ⫽ kobs) is first plotted as a
function of total [ANS], and the ratio between the intercept (koff) and the
slope (kon) of this plot is used to calculate a dissociation constant (Kd ⫽
koff/kon). This preliminary Kd is used along with the known total concentrations of ANS and ALBP in each sample to calculate new equilibrium concentrations for ANS and ALBP, which are then used to generate a new plot of 1/ versus [ANS]eq ⫹ [ALBP]eq. Seven to ten
iterations of this procedure were sufficient to achieve excellent
convergence.
Analytical Ultracentrifugation—Sedimentation equilibrium experiments were performed in 10 mM potassium phosphate, pH 7.5, at low
(50 mM) and high (1 M) KCl concentrations, in a Beckman Optima XL-A
analytical ultracentrifuge. The sample and reference sectors of Epon
charcoal-filled double-sector cells were loaded, respectively, with 110 l
of unligated or ANS-bound ALBP in low or high salt buffer and 125 l
of the corresponding buffer. For the runs in the presence of ANS, the
reference sector also contained ANS, the ANS concentration was ⬃100
M, and the samples contained 1% ethanol. Runs were performed at
20 °C and 25,000 rpm for ⬃24 h. Absorbance was measured at 279 nm
for unligated ALBP and 281 nm for ANS-bound ALBP. The ALBP
concentration was 0.2 mg/ml. Data were analyzed using the Origin
equilibrium analysis program in the Beckman analysis software package. Values of the partial specific volume of ALBP and the densities of
the buffer solutions at 20 °C were calculated using the computer program SEDNTERP (available on the World Wide Web at biochem.
uthscsa.edu/auc/software). Fitting data to models of higher oligomeric
complexity did not reveal any contaminants or additional equilibria and
confirmed that the data depict an ideal single species in solution.
RESULTS

Salt Significantly Stabilizes ALBP—Native ALBP displays a
CD spectrum typical of a protein predominantly consisting of
␤-sheet. Fig. 2A shows the change in the CD spectrum as urea
unfolds the protein. The largest spectral changes occur in the
␤-sheet trough around 217 nm, so for each denaturation the
signals at wavelengths of 216, 217, and 218 nm were individually analyzed and averaged to obtain values for ⌬Gunfolding as
described under “Experimental Procedures.” Fig. 2B shows
representative denaturation curves for ALBP in different solution conditions. Urea denaturations of apo-ALBP at 25 °C as a
function of added KCl reveal a significant (3 kcal/mol) saltinduced stabilization of the protein as the salt concentration is
increased from 0 to 2 M (Table I). The salt stabilization effect on
apo-ALBP appears to be mostly saturated at KCl concentrations above 250 mM. Measurements of the ⌬Gunfolding at 37 °C
in the presence and absence of 2 M KCl also show a significant
(5.1 kcal/mol) salt-induced stabilization of ALBP. Thus, at
37 °C, the addition of 2 M salt more than doubles the stability of
the protein. This is an extremely large salt-induced protein
stabilization.
Salt Appears to Destabilize Lipid-bound ALBP—In contrast
to the effect of salt on apo-ALBP, ANS-bound ALBP appears to
be destabilized by KCl. At 0 mM KCl, ANS-bound ALBP has a
free energy of unfolding of 9.7 kcal/mol. Additional stabilization
relative to the apoprotein is expected from the contribution of
the ANS binding energy. The binding of any ligand to a protein
will stabilize it. However, instead of exhibiting a pattern of
stabilization paralleling the apoprotein (offset by the added
⌬Gbinding of ANS), the holoprotein appears to become destabilized as salt is added. In general, the denaturation curves are

FIG. 2. Chemical denaturations of apo- and ANS-bound ALBP.
A, raw CD spectra of ALBP at increasing urea concentrations. Like
those of most predominantly ␤-sheet proteins, the CD spectrum of
native ALBP has a trough near 217 nm. The CD spectra of ALBP are
shown at 0, 6, and 8 M urea in 10 mM potassium phosphate, 50 mM KCl,
pH 7.5. Note the loss of CD signal intensity with added urea, indicative
of a loss of secondary structure and unfolding of the protein. B, representative urea-induced chemical denaturations of apo-ALBP (leftmost
set of curves, triangles, inverted triangles, and crosses) and ANS-bound
ALBP (rightmost set of curves, squares, diamonds, and circles), both at
50 mM KCl. Data were collected at 216, 217, and 218 nm for each
experiment, and each symbol shows data for a particular wavelength.
Lines through the data are best nonlinear fits to the linear extrapolation model (see “Experimental Procedures”).
TABLE I
⌬Gunfolding of ALBP with increasing KCl (in kcal/mol)
Values are the average of 3-6 ⌬Gunfolding values from individual
curves monitored at 216, 217, and 218 nm and fit with Equation 1 as
described under “Experimental Procedures.” All experiments were performed in 10 mM potassium phosphate buffer, pH 7.5, at the indicated
temperatures with the indicated amounts of added KCl.
[KCl] apo-ALBP, 25 °C

apo-ALBP, 37 °C

ANS-bound ALBP, 25 °Ca

4.0 ⫾ 1.0

9.7 ⫾ 2.0
8.7 ⫾ 1.1
7.1 ⫾ 1.0
6.7 ⫾ 0.9
6.8 ⫾ 0.7

mM

0
50
250
500
1000
2000

4.8 ⫾ 0.8
4.8 ⫾ 0.6
6.8 ⫾ 0.7
6.7 ⫾ 0.7
6.7 ⫾ 0.4
7.8 ⫾ 0.9

9.1 ⫾ 1.4

a

In all ANS-bound ALBP denaturations, the concentration of ANS
was 100 M.

less well behaved at high ANS concentrations, and this leads to
higher propagated errors on the determined free energies. This
situation results in significant overlap of the fitted ⌬Gunfolding
values in the presence of bound ANS (Table I). However, although the error envelopes overlap, the low salt data cannot
be fit using the high salt value of ⌬Gunfolding (6.8 kcal/mol), and
the high salt data cannot be fit using the low salt value of
⌬Gunfolding (9.7 kcal/mol). Furthermore, the data clearly and
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statistically significantly indicate that unlike the case for apoALBP, the ⌬Gunfolding for holo-ALBP is not increasing with
added salt. As discussed below, direct lipid binding experiments were conducted, which demonstrate that a major source
(but not the sole source) of this effect is the salt-induced displacement of ANS from the protein. Thermodynamic linkage
calculations indicate that this effect is coupled with a saltinduced increase of the affinity of ANS for the denatured state
of ALBP. The combination of these two effects produces the
observed results and results in the observed convergence of the
stabilization energies for the apo- and holoproteins at higher
salt concentrations (see “Thermodynamic Linkages among Stability, Ligand Binding, and Salt”).
All of the unfolding data fit well to a two-state denaturation
model (Equation 1). It is, however, possible that the observed
stabilization is the result of a salt-induced shift between a
two-state unfolding process and a three-state unfolding process
(which would have a lower apparent ⌬Gunfolding when analyzed
as a two-state process). If this were true, however, the shift for
the apoprotein would have to be three-state to two-state with
added salt, whereas the shift for holoprotein would have to be
two-state to three-state.
Salt Inhibits Lipid Binding to ALBP and Causes Lipid Release—Equilibrium binding of ANS to ALBP was measured
using the intrinsic fluorescence increase of ANS upon binding.
ANS binds specifically in the lipid binding cavity of ALBP (4, 8)
and competes directly with the binding of other lipids (7). Fig.
3A shows representative titrations at different KCl concentrations. Binding as a function of increased salt reveals that KCl
weakens the association between ANS and ALBP. The Kd of
ANS binding to ALBP increases from 0.48 to 4.4 M upon
increasing the KCl concentration from 50 to 750 mM (see Fig. 3
and Table II).
A thermodynamic linkage analysis of these data is also
shown in Fig. 3. The slope of a plot of ln [salt] versus ln(1/Kd)
provides an estimate of the net uptake or displacement of ions
upon ligand binding (26, 27). Fig. 3 shows that there exists a
thermodynamic linkage of ⬃0.8 ions released upon binding of
ANS. In other words, ANS binding causes the dissociation of
essentially one monovalent ion from ALBP. Since thermodynamic linkages must be reciprocal, adding salt to holo-ALBP
must also displace bound ligand. The salt-induced dissociation
of ANS from ALBP was confirmed by titrating KCl into ANSbound ALBP and observing the concomitant loss of fluorescence as the ANS dissociated (Fig. 3C). Note that ANS still
binds to ALBP at high salt (Table II and data not shown), so
Fig. 3C does not represent 100% displacement of ANS from the
protein but shows a salt-induced equilibrium shift at one concentration of ANS. Analysis of the salt-induced displacement of
ANS with a simple inverse isotherm (Equation 2), representing
competitive inhibition, yields an IC50 value of 172 mM KCl.
Salt Effects on the Kinetics of ANS-ALBP Binding—The kinetics of ANS association with ALBP were monitored by
stopped flow fluorescence spectroscopy over a range of ANS
concentrations at 50 mM and 1 M KCl. Fig. 4A shows representative kinetic curves at low and high salt concentrations along
with fits of the data to single exponential equations. Since the
mixing of ANS and ALBP is essentially a relaxation toward
equilibrium, the observed kinetic process will include contributions from both the association (kon) and dissociation (koff)
reactions. Relaxation kinetic processes display exponential progress toward equilibrium, and analysis of the resulting time
constants as a function of differing concentrations of reactants
is used to determine the kon and koff constants for the reaction.
The values of 1/ for the association of ANS and ALBP are
plotted as a function of the sum of the equilibrium concentra-
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FIG. 3. Dependence of ANS-ALBP binding on salt. A, shown are
representative equilibrium binding titrations monitoring the normalized change in fluorescence upon binding of ANS to ALBP in the
presence of 50 mM (circles), 250 mM (squares), and 750 mM (diamonds)
KCl. B, linkage plot of the relationship between ANS binding and KCl
concentration. The slope of approximately ⫺0.8 calculated from this
plot suggests the release of one monovalent ion upon the binding of one
ANS, and vice versa. C, salt-induced dissociation of ANS from ALBP.
Concentrated KCl (4 M) in 10 mM potassium phosphate at pH 7.5 was
titrated into 0.05 M ALBP and 5.5 M ANS. The addition of KCl causes
the dissociation of ANS from ALBP and a concomitant loss of fluorescence. The line fit through the data is a simple inverse isotherm (see
“Experimental Procedures”).

tions of ANS and ALBP in Fig. 4B for both low and high salt.
The slopes of these plots yield the kon, whereas the intercepts
provide koff (28). Both the on and off rates are altered by salt,
and the determined rate constants are reported in Table III.
The addition of salt slows down the association of ANS with
ALBP by more than 50% and speeds up the dissociation of ANS
from ALBP by almost 3-fold. The quantitative determination of
koff in the rapid mixing experiments exhibits lower precision
(higher error) largely because the on-rate dominates the observed relaxation at experimentally accessible reactant concentrations, but it can be clearly seen in Fig. 4B that the intercept
of kobs versus 1/ (which determines koff) is certainly larger at 1
M KCl than at 50 mM, indicating a salt-induced increased off
rate.
The association of ANS with ALBP is quite fast, possibly
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TABLE II
ANS-ALBP binding as a function of KCl
Values are from fits to Equation 2 as described under “Experimental
Procedures.” Reported values at 150, 500, and 750 mM KCl are from
single titrations, and values at 50 and 250 mM KCl are averages from
six and three-titrations, respectively; however, this entire series was
replicated several times with essentially identical results (data not
shown). All experiments were performed at 25 °C, in 10 mM potassium
phosphate buffer, pH 7.5, with the indicated amount of potassium
chloride.
[KCl]

Kd

⌬G

mM

M

kcal/mol

0.48 ⫾ 0.14
1.37 ⫾ 0.05
1.21 ⫾ 0.43
2.27 ⫾ 0.20
4.40 ⫾ 0.07

8.62 ⫾ 2.54
7.99 ⫾ 0.29
8.07 ⫾ 2.88
7.69 ⫾ 0.67
7.30 ⫾ 0.12

50
150
250
500
750

FIG. 4. Salt effects on the kinetics of ANS-ALBP binding. A,
representative curves showing the increase in fluorescence with time as
ANS associates with ALBP. Experiments were performed in 10 mM
potassium phosphate, pH 7.5, at 50 mM and 1 M KCl. The ANS concentrations for the curves shown were 23.4 M (50 mM KCl) and 27.1 M (1
M KCl). To obtain a sufficient density of data points on short and long
time scales, data were collected for 100- and 1000-ms durations. The
resulting exponential curves were averaged and collated before analysis; thus, each kinetic constant represents a fit of 5–12 data sets. The
fluorescence change has been normalized, and time 0 depicts the time of
completion of injection/mixing. B, this plot shows the reciprocals of the
observed time constants for ALBP-ANS association as a function of the
sum of the equilibrium concentrations of ANS plus ALBP. The plot was
generated as described under “Experimental Procedures.” The slopes of
these dependences yield kon, and the y intercepts are koff . Note that as
[KCl] increases, the on-rate decreases and the off-rate increases.

even diffusion-controlled. Thus, in order to capture a significant portion of the kinetic process, all of the kinetics measurements were performed at 6 °C. Accordingly, it can be seen that
the Kd values for binding of ANS to ALBP calculated from the
koff/kon ratios at 6 °C (Table III) are higher than those determined by direct binding at 25 °C (Table II) but that the same
reduction in binding affinity with added KCl occurs at both
temperatures. The decrease in binding affinity with decreased

TABLE III
Kinetics of ANS binding to ALBP at low and high salt
The top portion shows fitted time constants (kobs) for the association
of ANS with ALBP at different reactant concentrations. Values are the
results of fits of a single exponential to averaged data from 5–12
replicates. The concentration of ALBP was held constant at 2.5 M. All
experiments were carried out at 6 °C in 10 mM potassium phosphate
buffer, pH 7.5, with either 50 mM or 1 M potassium chloride. The bottom
portion shows correspondingly determined values of kon and koff (as
described under “Experimental Procedures”) and Kd for ANS binding at
high and low salt (Kd ⫽ koff/kon).
50 mM KCl

1

M

KCl

[ANS]

kobs

[ANS]

kobs

M

s⫺1

M

s⫺1

9.38
14.1
18.8
23.4
28.1
32.8

102 ⫾ 1
127 ⫾ 2
153 ⫾ 2
216 ⫾ 4
263 ⫾ 8
288 ⫾ 10

10.8
21.7
27.1
32.5
43.3
54.2

99 ⫾ 1
142 ⫾ 2
174 ⫾ 3
190 ⫾ 4
197 ⫾ 11
285 ⫾ 11

kon (s⫺1 M⫺1)
koff (s⫺1)
Kd (M)

8.9 ⫾ 0.6 ⫻ 106
21 ⫾ 13
2.3

kon (s⫺1 M⫺1)
koff (s⫺1)
Kd (M)

4.0 ⫾ 0.5 ⫻ 106
56 ⫾ 18
14

temperature in this temperature range is consistent with previous observations (8). Although ANS binds to ALBP with
negative enthalpy (8), there is a negative heat capacity change
(⌬Cp) upon binding (8), which results in curvature of the van’t
Hoff plot for ANS binding, such that affinity will increase with
temperature at lower temperatures and then will decrease with
temperature at higher temperatures.
Salt Stabilization of ALBP Is Not Linked to Protein Oligomerization—Salt-induced oligomerization of ALBP would be
one of the simplest molecular mechanisms that could potentially account for the relatively large stabilization of ALBP by
salt. Formation of dimers or higher order oligomers of any
protein would result in a higher apparent ⌬Gunfolding due to the
additional stabilization free energy from the protein-protein
interactions in the oligomer. Sedimentation equilibrium centrifugation is one of the most sensitive and reliable methods for
detecting oligomerization of proteins. Fig. 5 shows sedimentation equilibrium profiles for ALBP in 50 mM and 1 M KCl. Both
profiles reflect a well behaved monomeric protein. Parallel
experiments in the presence of 100 M ANS (data not shown)
contained more noise in the data due to the ANS but also fit a
single species of monomeric molecular weight. The amino acid
sequence based molecular weight of ALBP is 14,578. The mean
molecular weight returned by all four sedimentation equilibrium experiments (50 mM KCl with or without ANS and 1 M
KCl with or without ANS) was 14,976 ⫾ 7%. These data clearly
demonstrate that there is not an oligomerization reaction
linked to the lipid-binding or KCl-induced effects on ALBP.
DISCUSSION

We have demonstrated that KCl alters the stability, the ANS
binding equilibrium, and the ANS binding kinetics of ALBP.
Below, we discuss the thermodynamic linkages among these
effects, potential molecular origins of these effects, and potential intracellular consequences of these effects.
Thermodynamic Linkages among Stability, Ligand Binding,
and Salt—Fig. 6 illustrates the energetic linkages among
ALBP stability, ANS binding to ALBP, and salt effects on
ALBP as a thermodynamic cube. The front face of this cube
depicts the stability and ANS binding equilibria for ALBP in
the absence of excess salt: ⌬G1 is the folding/unfolding of apoALBP, ⌬G2 is the binding of ANS to ALBP, ⌬G3 is the folding/
unfolding of ALBP with ANS bound, and ⌬G4 is the binding of
ANS to the denatured state of ALBP. The back face of this
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FIG. 5. ALBP is monomeric at low and high salt concentrations. Concentration distributions at sedimentation equilibrium during
analytical ultracentrifugation are shown for ALBP at 50 mM (circles)
and 1 M (triangles) KCl concentrations. Lines through the data show the
fits to the concentration distribution of a monomeric, ideal particle at
sedimentation equilibrium. The upper panels show the residuals of the
fits for the two experiments.

FIG. 6. Thermodynamic linkages among unfolding, ANS binding, and the effects of salt on ALBP. Each reciprocal arrow represents an equilibrium process such as binding or unfolding. The front
face of the cube (with boldface arrows) is ALBP at low salt, and the far
face of the cube (with thinner arrows) is ALBP at higher salt. The right
face of the cube is ALBP with ANS bound, and the left face is ALBP
without ANS bound. The top face shows ANS and KCl binding to the
native state of ALBP, and the bottom face shows ANS and KCl binding
to the denatured state of ALBP.

thermodynamic cube represents these same four equilibria in
the presence of added salt (⌬G9, ⌬G10, ⌬G11, ⌬G12). The remaining four free energies connecting the front and back faces
of the cube correspond to the energetic consequences of adding
salt to the native apo- and holo-ALBP molecules (⌬G5, ⌬G6),
and the denatured apo- and holo-ALBP molecules (⌬G8, ⌬G7).
This thermodynamic cube thus illustrates the energetic relationships among stability, lipid binding, and salt effects that
govern the structural and functional status of ALBP under any
particular combination of these parameters. Furthermore,
these thermodynamic relationships can be used to calculate the
values of energetic parameters that have not or cannot be
directly measured. For example, at any particular salt concentration, the depicted thermodynamic linkage can be used to
calculate the free energy of binding of ANS to the denatured
state of ALBP. At 50 mM KCl, the value of ⌬G4 (dissociation of
ANS from the denatured state) is 4.7 kcal/mol (⌬G1 ⫹ ⌬G2 ⫺
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⌬G3 ⫽ 4.8 kcal/mol ⫹ 8.6 kcal/mol ⫺ 8.7 kcal/mol). Defined in
the binding direction, the ⌬Gassociation of ANS to the denatured
state at 50 mM will therefore be ⫺4.7 kcal/mol. This calculation
provides the total free energy of binding of ANS to the denatured state as determined by conservation of energy but does
not provide information on the stoichiometry of the reaction.
This calculation of the energy of ANS binding to the denatured state illustrates why binding of ANS to ALBP at 50 mM
KCl does not appear to stabilize the native state of the protein
as much as would be expected. Conservation of energy dictates
that the binding of any ligand to a protein will increase its
stability (29). ANS binding to ALBP at 50 mM KCl should
stabilize the protein by an additional 8.6 kcal/mol (its dissociation free energy). However, because ANS also binds to the
denatured state of ALBP, the stabilities of both the denatured
and native states have been increased. Due to ANS binding, the
denatured state is stabilized by 4.7 kcal/mol, and the native
state is stabilized by 8.6 kcal/mol, yielding a difference between
them of 3.9 kcal/mol.
Similar calculations can be performed at higher salt, with
interesting conclusions. For example, at 500 mM KCl, the value
of ⌬G12 (dissociation of ANS from the denatured state) is calculated to be 7.7 kcal/mol (⌬G9 ⫹ ⌬G10 ⫺ ⌬G11 ⫽ 6.7 kcal/mol ⫹
7.7 kcal/mol ⫺ 6.7 kcal/mol). The ⌬Gassociation of ANS to the
denatured state at 500 mM salt is therefore ⫺7.7 kcal/mol.
Thus, notably, thermodynamic linkage shows that increased
salt will increase the affinity of ANS for the denatured state of
ALBP. This suggests that binding of ANS to the denatured
state of ALBP is dominated by hydrophobic interactions. Furthermore, this calculation explains the unusual finding that
the unfolding free energies of apo-ALBP and holo-ALBP essentially converge at high salt (see Table I). This convergence is
unexpected at first, again because conservation of energy dictates that ANS binding to ALBP will increase its stability, and
ANS still binds to native ALBP with micromolar affinity even
at high salt concentrations. Thus, one would normally expect
the lipid-bound protein to always have a higher free energy of
unfolding than the apoprotein, even at high salt. However, at
high salt, the affinities of ANS for the native and the denatured
forms of ALBP are calculated via the thermodynamic linkage to
be essentially equal. This means that binding of ANS at high
salt will not preferentially stabilize either state of the protein.
Thus, although ANS is binding to ALBP at high salt, the net
effect of ANS binding on stabilization disappears, and the
stabilization free energies of the apo- and holo-forms of the
protein converge at high salt.
These thermodynamic relationships are dictated by mass
and energy balance and are effectively “model-independent.” In
other words, whereas we discuss several potential molecular
mechanisms for the action of salt below, the thermodynamic
relationships shown in Fig. 6 and discussed above will hold
regardless of the particular molecular mechanism producing
these effects. The characterization of the binding of ANS to the
denatured states of ALBP discussed above is one of the first
quantitative determinations of the binding free energy of ANS
to the denatured state of any protein.
Potential Molecular Origins of the Effects of Salt on ALBP—
Added salts have long been known to have both stabilizing and
destabilizing effects on many proteins (30 –37). The magnitude
of the salt stabilization of ALBP observed herein is on the high
side of salt-induced protein stabilization effects. A number of
molecular mechanisms have been proposed to explain the effects of salt on protein stability, including preferential hydration, specific ion binding, and electrostatic screening of surface
charge repulsions (30 –37); however, clear assignment of the
origins of a salt-induced effect to a particular molecular model
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has only been accomplished for a few well characterized systems. Relative to stability studies, far fewer studies of the salt
effects on ligand binding to proteins have been performed, with
the notable exception of DNA-binding proteins, where characterization of the salt dependence of binding is usually one of the
first and primary empirical characteristics examined. In contrast, investigations of the salt effects on the binding of lipids to
proteins are scarce.
Molecular models for explaining the effects of added salt on
protein stability and function can be divided into several categories. Salt effects may be general (independent of the ion type)
or ion-specific. In addition, such general or specific salt effects
may be manifested via effects of the salt on the solvent environment, or they may involve direct ion binding to the protein.
Furthermore, the effects of salt on ligand binding in particular
may involve direct competitive inhibition due to ion binding in
the active site, or indirect long range allosteric effects due to
ion binding at a remote site or sites. The current data for
ALBP, while demonstrating salt-induced modulation of the
stability and function of the protein, afford only initial discussion of possible molecular origins for these effects.
One general model consistent with the current results for
ALBP is charge screening. Any time two charged molecules
interact in a solution containing added salt, the tendency of
solvent ions to surround and screen the two interacting molecules effectively reduces their effects upon each other. Thus,
the electrostatic attraction between ANS and ALBP would be
reduced and could account for the reduction of binding affinity
in the presence of increased salt. Effects of salt on stability can
similarly be explained as a screening of repulsive interactions.
The electrostatic topology of ALBP, as seen in Fig. 1, shows
that large patches or clusters of like charge occur on the surface
of the protein. As has been proposed by Fink and associates (33,
37), added salt would screen the repulsive interactions within
each extended patch and thus stabilize the protein.
Conformational tightening or constriction of a protein’s
structure has been proposed in other systems to explain the
effects of salt and ANS on the stability of some proteins (38). At
first glance, such a mechanism might seem applicable to the
data on ALBP. It is known that conformational flexibility is
required for the binding of lipids to ALBP (4). Structural studies of ALBP have shown that whereas there is a large stable
lipid binding cavity both in the presence and absence of bound
lipid, there is no stable access channel to this cavity (4). Thus,
the protein must conformationally flex in order for lipids to
enter and leave the cavity. Salt-induced conformational tightening of ALBP could both stabilize the protein and reduce lipid
binding affinity. However, the kinetics of lipid binding and
release determined in this study rule out this attractive model.
Restriction of structural mobility would make it more difficult
for lipids to both enter and leave the cavity. However, the data
in Fig. 4 and Table III show that in the presence of added salt,
the association rate for ANS binding is reduced, but the dissociation rate is increased. This is a somewhat simplistic projection of the potential functional consequences of conformational
tightening, however. Furthermore, determinations of kinetic
constants such as koff are always kinetic mechanism-dependent, and whereas the kinetic data in this study are well described by a simple relaxation mechanism, the situation could
be more complicated. Thus, whereas the salt effects on koff as
presented appear to rule out conformational tightening, further
exploration of this model may still be warranted.
Along with charge screening, discussed above, another major
molecular model that would be consistent with all of the current data for ALBP is a specific ion binding event. The nearly
1:1 reciprocal linkage between salt and ANS binding (Fig. 3)

suggests such a model. If the salt-induced stabilization of the
protein is similarly analyzed as a thermodynamic linkage using
Equation 3 as described under “Experimental Procedures”
(analysis not shown), it suggests an uptake of between 0.6 and
1.0 ions upon stabilization of ALBP by salt. It is possible that
direct ion binding could both stabilize the protein and compete
directly with ANS for binding to the protein. The most extreme
form of this model would be the simultaneous stabilization of
the protein and reduction of lipid binding affinity via the binding of a single ion to a single site on the protein.
The investigation of the effects of different salts on a protein
and the site-directed mutation of potential ion binding sites are
two approaches to determining whether salt effects are ionspecific or general and are two foci of future studies in our
laboratory. Preliminary results suggest that the thermodynamic linkage between salt and ANS binding does change
somewhat with salts other than KCl (work in progress), suggesting that the modulation of ANS binding does have some
ion-specific character. Ion-specific binding and general charge
screening are not mutually exclusive mechanisms, and both
may be involved in the salt modulation of the stability and
function of ALBP. The data in this study, however, indicate
that conformational tightening and linked higher order oligomerization are not involved in manifestation of the salt regulation of ALBP. Much of this discussion has to some extent
effectively assumed that the underlying mechanisms for the
salt effects on stability and lipid binding are the same or
overlap at the molecular level, and this may not be the case. It
is certainly possible that the two effects, while thermodynamically linked, do not share the same molecular origins.
Potential in Vivo Consequences of the Salt Regulation of
ALBP—The effects of KCl on the stability and lipid binding
affinity of ALBP have been examined across wide concentration ranges in order to help definitively establish and quantitate these effects. These data show, however, that these effects
will occur under physiological salt conditions. Within the cell,
ALBP will have higher stability and lower lipid affinity than
would be predicted from previously reported in vitro studies.
Furthermore, the midpoints of the salt effects on both stability
and lipid binding are near physiological salt concentrations.
The IC50 for the salt displacement of ANS from ALBP is 172
mM (Fig. 3). The major portion of the salt stabilization of ALBP
occurs between 50 and 250 mM KCl (Table I). The normal
intracellular concentration of potassium is ⬃139 mM (39, 40).
The midpoints of these effects are where they will be highly
sensitive to salt modulation. This means that small changes in
the physiological salt concentration will directly regulate the
activity and structural stability of ALBP. Decreases in intracellular potassium concentrations of 18% have been linked to
type 2 diabetes (40).
In an elegant series of studies, Storch and associates have
demonstrated that ALBP transfers fluorescent fatty acids to
lipid membranes via a direct collisional mechanism (11–13).
Salt effects on the transfer rate of fluorescent fatty acids from
ALBP to lipid vesicles have been used as one of many criteria
for postulating the direct interactions between ALBP and lipid
vesicles. Whereas many other avenues of evidence have been
used to demonstrate these direct interactions, the salt-induced
release of bound lipid demonstrated in Fig. 3 and the salt
effects on the kinetics of lipid binding shown in Fig. 4 indicate
that salt effects in lipid transfer assays may not unequivocally
be used as a sole indicator of the existence of collisional donoracceptor interactions with ALBP.
Linkages among salt, hypertension, and insulin resistance
have been noted for many years in diabetes research (e.g. Refs.
41 and 42), including linkages to fatty acid metabolism (43).
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ALBP itself has been directly linked to obesity, diabetes, and
atherosclerosis (6, 44, 45). ALBP has been shown to localize to
the nucleus in the early stages of adipocyte differentiation (46)
and in response to cellular uptake of certain nuclear hormone
receptor ligands (47). In the nucleus, ALBP interacts directly or
indirectly with peroxisome proliferator-activated receptor ␥
(PPAR␥) (47, 48). PPAR␥ is a nuclear hormone receptor that is
activated by fatty acids and other intracellular lipids (49).
PPAR␥ controls adipocyte differentiation, including the direct
transcriptional regulation of ALBP expression (for reviews, see
e.g. Refs. 50 and 51). Depending on the circumstances and the
particular lipid involved, ALBP can apparently either deliver
activating lipids to PPAR␥ (47) or competitively deplete ligands
from PPAR␥ (48).
Because salt regulates the lipid binding activity of ALBP, it
would also regulate the transfer of lipids between ALBP and
PPAR␥ in the nucleus. The existence of potassium gradients
between the nucleus and the cytoplasm has recently been demonstrated in hepatocytes (52). Such gradients and the likely
presence of higher overall amounts of salt in the nucleus relative to the cytoplasm due to the presence of electrostatically
balancing counterions localized near DNA could have a definite
impact on this important intracellular signaling interaction.
One scenario might envision ALBP simply releasing some ligands upon entering the nucleus due to interactions with the
differing ionic environment relative to the cytoplasm. As more
studies emerge focusing on the electrostatic aspects of lipidprotein interactions, so should a more complete understanding
of the balance between hydrophobic forces and electrostatic
forces in controlling these important intracellular interactions.
REFERENCES
1. Banaszak, L., Winter, N., Xu, Z., Bernlohr, D. A., Cowan, S., and Jones, T. A.
(1994) Adv. Protein Chem. 45, 89 –151
2. Bernlohr, D. A., Simpson, M. A., Hertzel, A. V., and Banaszak, L. J. (1997)
Annu. Rev. Nutr. 17, 277–303
3. Stewart, J. M. (2000) Cell. Mol. Life Sci. 57, 1345–1359
4. Layne, M. D., Patel, A., Chen, Y.-H., Rebel, V. I., Carvajal, I. M., Pellacani, A.,
Ith, B., Zhao, D., Schreiber, B. M., Yet, S.-F., Lee, M.-E., Storch, J., and
Perrella, M. A. (2001) FASEB J. 15, 2733–2735
5. Perrella, M. A., Pellacani, A., Layne, M. D., Patel, A., Zhao, D., Schreiber,
B. M., Storch, J., Feinberg, M. W., Hsieh, C. M., Haber, E., and Lee, M. E.
(2001) FASEB J. 15, 1774 –1776
6. Hotamisligil, G. S., Johnson, R. S., Distel, R. J., Ellis, R., Papaioannou, V. E.,
and Spiegelman, B. M. (1996) Science 274, 1377–1379
7. Kane, C. D., and Bernlohr, D. A. (1996) Anal. Biochem. 233, 197–204
8. Ory, J. J., and Banszak, L. J. (1999) Biophys. J. 77, 1107–1116
9. Nicholls, A., Sharp, K., and Honig, B. (1991) Proteins 11, 281–296
10. LiCata, V. J., and Bernlohr, D. A. (1998) Proteins 33, 577–589
11. Wootan, M. G., Bernlohr, D. A., and Storch, J. (1993) Biochemistry 32,
8622– 8627
12. Wootan, M. G., and Storch, J. (1994) J. Biol. Chem. 269, 10517–10523
13. Smith, E. R., and Storch, J. (1999) J. Biol. Chem. 274, 35325–35330

33275

14. Jakoby, M. G., Miller, K. R., Toner, J. J., Bauman, A., Cheng, L., Li, E., and
Cistola, D. P. (1993) Biochemistry 32, 872– 878
15. Kirk, W. R., Kurian, E., and Prendergast, F. G. (1996) Biophys. J. 70, 69 – 83
16. Matulis D., and Lovrien R. (1998) Biophys. J. 74, 422– 429
17. Xu, Z., Buelt, M. K., Banaszak, L. J., and Bernlohor, D. A. (1991) J. Biol. Chem.
226, 14367–14370
18. Simpson, M. A., and Bernlohr, D. A. (1998) Biochemistry 37, 10980 –10986
19. Matarese, V., and Bernlohr, D. A. (1988) J. Biol. Chem. 263, 14544 –14551
20. Pace, C. N. (1986) Methods Enzymol. 14, 266 –280
21. Johnson, W. C., Jr. (1988) Annu. Rev. Biophys. Biophys. Chem. 17, 145–166
22. Santoro, M. M., and Bolen, D. W. (1988) Biochemistry 27, 8063– 8068
23. Heyduk, T., and Lee, J. C. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 1744 –1748
24. Inglese, J., Blatchly, R. A., and Benkovic, S. J. (1989) J. Med. Chem. 32,
937–940
25. Datta, K., and LiCata, V. J. (2003) J. Biol. Chem. 278, 5694 –5701
26. Wyman, J. (1964) Adv. Protein Chem. 19, 223–286
27. Lohman, T. M., and Mascotti, D. P. (1992) Methods Enzymol. 212, 400 – 424
28. Bernasconi, C. F. (1976) Relaxation Kinetics, Academic Press, Inc., pp. 11–13,
New York
29. Schellman, J. A. (1987) Annu. Rev. Biophys. Biophys. Chem. 16, 115–137
30. von Hippel, P. H., and Schleich, T. (1969) in Structure and Stability of Biological Macromolecules in Solution (Timasheff, S. N., and Fasman, G. D., eds)
pp. 417–574, Marcel Decker, Inc., New York
31. Schellman, J. A. (1987) Biopolymers 26, 549 –559
32. Pace, C. N., and Grimsley, G. R. (1988) Biochemistry 27, 3242–3246
33. Goto, Y., Takahashi, N., and Fink, A. L (1990) Biochemistry 29, 3480 –3488
34. Arakawa, T., Bhat, R., and Timasheff, S. N. (1990) Biochemistry 29,
1924 –1931
35. Yang, A. S., and Honig, B. (1992) Curr. Opin. Struct. Biol. 2, 40 – 45
36. Timasheff, S. N. (1995) Methods Mol. Biol. 40, 253–269
37. Nishimura, C., Uversky, V. N., and Fink, A. L. (2001) Biochemistry 40,
2113–2128
38. Matulis, D., Baumann, C. G., Bloomfield, V. A., and Lovrien, R. E. (1999)
Biopolymers 49, 451– 458
39. Lodish, H. Berk, A., Zipursky, S. L., Matsudaira, P., Baltimore, D., and
Darnell, J. (1999) in Molecular Cell Biology, 4th Ed., p. 585, W. H. Freeman
and Co., New York
40. Resnick, L. M. Barbagallo, M., Dominguez, L. J., Veniero, J. M., Nicholson,
J. P., and Gupta, R. K. (2001) Hypertension 38, 709 –712
41. Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M.,
Graziadei, L., Pedrinelli, R., Brandi, L., and Bevilacqua, S. (1987) N. Engl.
J. Med. 317, 350 –357
42. Ogihara, T., Asano, T., Ando, K., Chiba, Y., Sekine, N., Sakoda, H., Anai, M.,
Onishi, Y., Fujishiro, M., Ono, H., Shojima, N., Inukai, K., Fukushima, Y.,
Kikuchi, M., and Fujita, T. (2001) Diabetes 50, 573–583
43. Donovan, D. S., Soloman, C. G., Seely, E. W., Williams, G. H., and Simonson,
D. C. (1993) Am. J. Physiol. 264, E730 –E734
44. Makowski, L., Boord, J. B., Maeda, K., Babaev, V. R., Uysal, K. T., Morgan,
M. A., Parker, R. A., Suttles, J., Fazio, S., Hotamisligil, G. S., and Linton,
M. F. (2001) Nat. Med. 7, 699 –705
45. Berg, J. P. (1997) Eur. J. Endocrinol. 136, 467– 468
46. Helledie, T., Antonius, M., Sorenson, R. V., Hertzel, A. V., Bernlohr, D. A.,
Kolvraa, S., Kristiansen, K., and Mandrup, S. (2000) J. Lipid Res. 41,
1740 –1751
47. Tan, N. S., Shaw, N. S., Vinckenbosch, N., Liu, P., Yasmin, R., Desvergne, B.,
Wahli, W., and Noy, N. (2002) Mol. Cell. Biol. 22, 5114 –5127
48. Helledie, T., Jorgensen, C., Antonius, M., Krogsdam, A. M., Kratchmarova, I.,
Kristiansen, K., and Mandrup, S. (2002) Mol. Cell Biochem. 239, 157–164
49. Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble,
C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., and
Lehmann, J. M. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 4318 – 4323
50. Grimaldi, P. A. (2001)) Prog. Lipid Res. 40, 269 –281
51. Spiegelman, B. M. (1998) Diabetes 47, 507–514
52. Garner, M. H. (2002) J. Membrane Biol. 187, 97–115

